20 apr: Nye stærkere Porsche Cayenne GTS
23 apr: Speas vinder på PE-fondes effektiviseringer
20-04-2012 12:46:00

Schlumberger 1Q Net Rose 38% On Solid North America Revenue

Relateret indhold

DOW JONES NEWSWIRES

Schlumberger Ltd.'s (SLB) first-quarter earnings rose 38% as the shift of rigs and services to liquids-rich basins continued to drive revenue growth.

Schlumberger, the world's largest oil field services company, had seen its revenue soar in recent quarters as exploration and production companies ramp up activity in areas like the deep-water U.S. Gulf of Mexico and vast oil-rich shale formations around the U.S. Schlumberger has predicted oil consumption and oil field activity will continue to grow through 2012, driven by relatively high energy prices and large oil companies' expanding their reserves. The company's international performance has also been improving as political tensions eased in key geographies, like Libya, where Schlumberger resumed activity during the fourth quarter.

Schlumberger reported a profit of $1.3 billion, or 97 cents a share, up from $944 million, or 69 cents a share, a year earlier. Excluding items such as merger and integration costs, earnings rose to 98 cents from 71 cents. Revenue was $10.61 billion, a 22% jump from a year earlier, but down 3.3% from the prior quarter.

Analysts polled by Thomson Reuters had most recently forecast earnings of 97 cents on revenue of $10.55 billion.

Oil-field services revenue from North America, the region which generates most of the top-line, dropped 3.2% from the fourth quarter, reflecting the seasonal slowdown in product, software and multiclient sales. The company said North America revenue was flat sequentially, excluding seasonal sales effects.

Schlumberger said the move of rigs and service capacity from gas-rich to liquids-rich basins accelerated during the most-recent quarter, while the pricing weakness experienced in prior quarters reached the liquids-rich basins.

Internationally, the impact of winter weather and year-end sales affects lowered revenue, but growing higher-margin exploration and deepwater activity in a number of regions kept margins flat, sequentially.

The Europe/Commonwealth of Independent States/Africa region's revenue declined 3.3% from the prior quarter while the Middle East and Asia posted a 3.9% decrease. Latin America revenue was down 4.4%.

Shares closed Thursday at $69.80 and were inactive premarket. The stock has fallen 5.4% over the past three months.

--By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

(END) Dow Jones Newswires

April 20, 2012 06:46 ET (10:46 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Aktier/tendens: Genmab og Vestas fortsætter i fokus
3
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
4
Vestas ejer mere end 5 pct. egne aktier efter opkøb
5
Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

Relaterede aktiekurser

Schlumberger N.V. 63,67 -0,8% Fald i aktiekurs
Schlumberger 54,89 -0,4% Fald i aktiekurs
Schlumberger LD COM STK .. 62,55 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
13. december 2017 19:29:11
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB5 - 2017-12-13 19:29:11 - 2017-12-13 19:29:11 - 1 - Website: OKAY